Oncologists Accepting UMR in Boston, MAPage 6
181 verified oncologists in Boston, Massachusetts accept UMR. Profiles cover focus areas including Medical Oncology, Surgical Oncology, and GI Oncology. Common hospital affiliations include Dana-Farber Cancer Institute, Massachusetts General Hospital, and Brigham and Women's Hospital.
Mahasweta Gooptu, M.D.
Assistant Professor of Medicine, Harvard Medical School
Oncology
Andrew Aguirre, MD, PHD
Associate Professor of Medicine, Harvard Medical School
Oncology
Ko Un Park, M.D.
Oncology
Tara Berman, M.D.
Medical Oncologist, Dana-Farber Cancer Institute; Faculty Member, Harvard Medical School
Oncology
Zofia Piotrowska, MD
Associate Professor of Medicine, Harvard Medical School
Oncology
Charlene Mantia, M.D.
Instructor in Medicine, Harvard Medical School
Oncology
Payal Gupta, MD
Oncology
Genevieve Boland, MD, PHD
Vice Chair of Research, Department of Surgery; Director, Therapeutic Intralesional Program; Surgical Director, Termeer Center for Targeted Therapies; Associate Professor, Harvard Medical School
Oncology
Othon Iliopoulos, MD
Oncology
Martha Wadleigh, MD
Director, Inpatient Oncology; Assistant Professor of Medicine, Harvard Medical School
Oncology
Otto Metzger, M.D.
Director, International Strategic Initiatives; Assistant Professor of Medicine, Harvard Medical School
Oncology
Rochelle Scheib, MD
Professor of Medicine, Harvard Medical School
Oncology
Matthew Oser, M.D./PH.D.
Assistant Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School where he runs a research laboratory focused on small cell lung cancer and is a; Associate Professor of Medicine, Harvard Medical School
Oncology
Rizwan Haq, MD, PHD
Assistant Professor, Harvard Medical School
Oncology
Shayna Sarosiek, MD
Senior Physician; Assistant Professor of Medicine, Harvard Medical School
Oncology
Franklin Huang, MD, PHD
Oncology
Ting Bao, M.D.
Director of the Zakim Center for Integrative Therapies and Healthy Living at the Dana-Farber Cancer Institute. She was a joint faculty member at Memoria
Oncology
Amy Bregar, MD
Assistant Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School
Oncology
David Jackman, M.D.
Director for Clinical Pathways and New Business Initiatives. His research interests include targeted therapies in lung cancer and mesothelioma, and canc; Senior Physician
Oncology
Laura Spring, M.D.
Assistant Professor of Medicine, Harvard Medical School
Oncology